The company met the US Food and Drug Administration’s initial requirements under a pact reached last month, Abbott said in a blog post Saturday. A spokesperson also confirmed that the plant -- one of four facilities in the US -- is restarting baby formula production.
The pharmaceutical company
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
